Work

Rapid diagnosis of acute HIV-1 infection cases: first real-world performance of point-of-care HIV-1 nucleic acid testing in China

Year: 2025

Type: article

Abstract: Background Timely diagnosis of acute HIV infection (AHI) is critical for curbing transmission. However, the diagnostic window prior to antibody development limits the utility of conventional serological assays. Conventional laboratory-based nucleic acid testing (LABT) is often hindered by operational complexity and long turnaround times. Point-of-care nucleic acid testing (POCT) provides a rapid alternative. Methods This multicenter cross-sectional study enrolled 1,829 adults from 13 cities in Jiangsu Province and Kunming, Yunnan Province, who had reactive screening results but negative or indeterminate Western blot outcomes. The diagnostic accuracy, quantitative correlation, and agreement of the POCT (Xpert® HIV-1 Viral Load point-of-care test) were compared with LABT using the Roche COBAS TaqMan v2.0 or Abbott RealTime HIV-1 assays, with follow-up seroconversion serving as the reference standard. Turnaround time from initial screening to NAT result reporting was compared using Kaplan–Meier analysis. Laboratory staff perceptions of POCT usability were evaluated via questionnaire. Results Using follow-up seroconversion as a reference, POCT demonstrated a sensitivity of 98.87% and specificity of 100.00%, with almost perfect agreement with LABT (99.76%, Cohen’s κ = 0.994). Quantitative viral load results exhibited strong correlation between POCT and LABT ( r = 0.89), with 94.64% of paired measurements falling within the limits of agreement. POCT significantly reduced the median time from initial screening to result reporting compared to LABT (7 vs. 14 days, p < 0.001) and increased the likelihood of results being returned within 7 days (Hazard Ratio = 2.29, p < 0.001). Most laboratory personnel reported ease of use (30/33, 90.9%) and a preference for the POCT workflow (21/33, 63.6%). Conclusion The Xpert HIV-1 POCT provides a highly accurate and rapid alternative to LABT for diagnosing AHI in China. Its implementation can dramatically shorten diagnostic delays, potentially reducing loss to follow-up and onward transmission, thus offering significant value within the national HIV diagnostic framework.

Source: Frontiers in Public Health

DOI: 10.3389/fpubh.2025.1707432